Cullen/Frost Bankers, Inc.
NYSE:CFRBanks - Regional
-$0.75 today
- Market cap
- $9.82B
- Beta
- 0.55
- P/E (TTM)
- 13.8
- EPS (TTM)
- $10.51
- Dividend yield
- 2.77%
Volume 0.50M
Average 0.55M
CFR Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Cullen/Frost Bankers, Inc.NYSE: CFR
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How CFR compares with its peers on the latest reported figures
- CFR's LTM Jun 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for CFR, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CFR) | $0 | -100.0% | — | 0.0% | |
Competitors are the stored peer set for CFR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.4B | 1.88B | 2.65B | 2.85B | 2.92B |
| Cost of Revenue | 23.97M | 187.44M | 705.22M | 851.01M | 728.8M |
| Gross Profit | 1.37B | 1.69B | 1.94B | 2B | 2.19B |
| Gross Margin | 98.3% | 90.0% | 73.4% | 70.1% | 75.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 524.3M | 636.3M | 788.22M | 832.51M | 896.37M |
| Operating Expenses | 881.99M | 1.02B | 1.23B | 1.3B | 1.42B |
| Depreciation & Amortization | 69.29M | 71.34M | 76.44M | 82.82M | 87.79M |
| EBITDA | 558.83M | 740.17M | 788.82M | 778.78M | 859.49M |
| EBITDA Margin | 40.0% | 39.4% | 29.8% | 27.3% | 29.4% |
| Operating Income | 489.54M | 668.83M | 712.37M | 695.97M | 771.7M |
| Operating Margin | 35.1% | 35.6% | 26.9% | 24.4% | 26.4% |
| Interest Income | 1.01B | 1.48B | 2.22B | 2.39B | 2.42B |
| Interest Expense | 23.9M | 184.44M | 659.05M | 786.03M | 684.6M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 489.54M | 668.83M | 712.37M | 695.97M | 771.7M |
| Pre-Tax Margin | 35.1% | 35.6% | 26.9% | 24.4% | 26.4% |
| Income Tax Expense | 46.46M | 89.68M | 114.4M | 113.43M | 123.15M |
| Net Income | 443.08M | 579.15M | 597.97M | 582.54M | 648.56M |
| Net Margin | 31.8% | 30.8% | 22.6% | 20.4% | 22.2% |
| EPS (Basic) | 6.79 | 8.84 | 9.11 | 8.88 | 10.02 |
| EPS (Diluted) | 6.74 | 8.79 | 9.08 | 8.87 | 9.92 |
| Weighted Avg Shares | 63.61M | 64.16M | 64.2M | 64.19M | 64.05M |
| Weighted Avg Shares (Diluted) | 64.1M | 64.52M | 64.41M | 64.28M | 64.1M |
Cullen/Frost Bankers, Inc.
NYSE:CFR
Intrinsic Alpha fair value
Locked
Current Price
$157.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.